Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,790,482
+$2,525,195 QoQ
Shares Held
700,494
-12.9% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#79
of 494 holders
Holding Since
Mar 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Dec 31, 2023CallValue
$130,268
CallShares
11,600
PutValue
$130,268
PutShares
11,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names. ROIV ranks #43 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in ROIV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,790,482 | 700,494 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,265,287 | 803,801 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $25,987,746 | 1,197,592 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $39,157,922 | 2,588,098 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,886,448 | 965,967 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,642,147 | 162,750 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $1,948,505 | 184,343 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,090,173 | 388,062 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,456,080 | 1,109,179 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $130,268 | 11,600 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $130,268 | 11,600 | Put | Sole | 2024-02-14 | |
| 2023-09-30 | $26,112,053 | 2,235,621 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,095,438 | 1,695,976 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,014,707 | 408,497 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $502,499 | 62,891 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $269,475 | 83,688 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $692,518 | 140,186 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||